ACTRN12607000628448招募中2 期
A pilot study of combining rituximab and low-dose (1.0Gy) total nodal irradiation in treatment of extensive chronic graft-versus-host disease
Simon He and Andrew Grigg0 个研究点目标入组 20 人开始时间: 2007年12月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •active, extensive cutaneous chronic GVHD with suboptimal response to standard systemic immunosuppression
排除标准
- •(1) Chronic GVHD with irreversible end-organ damage (2) uncontrolled infection (3)
- •Severe cytopenias
研究者
相似试验
未知
2 期
Clinical study for effectiveness of rituximab for acquired coagulopathyacquired coagulopathyJPRN-UMIN000024612Gunma University10
已完成
2 期
A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07)Diffuse large B-cell lymphomaJPRN-UMIN000001050Clinical Hematology Study Group of National Hospital Organization (CHSG-NHO)40
进行中（未招募）
不适用
Pilot study to evaluate the effect of Rituximab in combination with MTX in the inhibition of progression of synovitis, bone marrow edema, and erosions evaluated by magnetic resonance imaging (MRI) in the hand of patients with rheumatoid arthritis. - NDMedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisRheumatoid arthritisEUCTR2007-001754-11-ITROCHE
尚未招募
不适用
A study comparing Rituximab/Bendamustin (RB) alternating with Rituximab/Bendamustin/Cytarabin (RBAC) with Rituximab/Bendamustin (RB) therapy in elderly patients with mentle cell lymphomaKCT0007009Samsung Medical Center90
已完成
2 期
Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaNCT00147953University of Cologne30